Skip to content

DERMATOLOOG DR. DEVOS

Active
Private limited company·Activiteiten van medisch specialisten· 20 yrs active
Arsenaalstraat 33/A ·8620 Nieuwpoort, Belgium
KBO/BCE: BE 0880.785.338
Watch Print / PDF
Age20 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of DERMATOLOOG DR. DEVOS is 0.1% (very low). The 2025 annual accounts show equity of €734k and a net result of €175k. Equity remains stable across the filed fiscal years (±0.3% per year). Its solvency ranks better than 73% of 5347 sector peers (fiscal year 2023). The company has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 8 annual accounts.

Signals

1 signal · with evidence
Consistently profitable
Positive net result in the two most recent financial years (2022 and 2023).
View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-07-2026, 2 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
How we compute the deadline
The year end is derived from 10 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2025, that is 31-07-2026.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 29-07-2026 2 d early 2026-00348962
31-12-2024 31-07-2025 29-07-2026 363 d late 2026-00349345
31-12-2023 31-07-2024 26-02-2025 210 d late 2025-00039524
31-12-2022 31-07-2023 21-02-2025 571 d late 2025-00037427
31-12-2021 31-07-2022 19-02-2025 934 d late 2025-00036487
31-12-2020 31-07-2021 30-09-2021 61 d late 2021-69600185
31-12-2019 31-07-2020 08-10-2020 69 d late 2020-60300452
31-12-2018 31-07-2019 13-08-2019 13 d late 2019-46300166
31-12-2017 31-07-2018 30-08-2018 30 d late 2018-56500206
31-12-2016 31-07-2017 30-08-2017 30 d late 2017-55600290

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
Long-established
Founded in 2006, 20 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.1% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Long track record Annual accounts: weaker financial profile +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€175k+2.5%
Working capital€655k+3.3%

Annual accounts & ratios

Source: NBB · 2025
Annual accounts filed on 29-07-2026 with the NBB · fiscal year 2025 · micro
€-100k€0€100k€200k€300kOperating result 2021: €-1k€-1kNet result 2021: €-14k€-14kOperating result 2022: €78k€78kNet result 2022: €55k€55kOperating result 2023: €294k€294kNet result 2023: €267k€267kOperating result 2024: €202k€202kNet result 2024: €171k€171kOperating result 2025: €201k€201kNet result 2025: €175k€175k20212022202320242025
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
stable Equity: stable across 8 fiscal years (±0.3%/year).
€500k€600k€700k€800k2026: €687k (€628k - €745k)2027: €685k (€602k - €767k)2028: €682k (€569k - €796k)2018: €697k2019: €765k2020: €685k2021: €671k2022: €726k2023: €570k2024: €699k2025: €734k20182019202020212022202320242025202620272028
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2023 · NACE 86, Human health · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 79.4% 65.7%
better than 73% of 5347 sector peers
Net result €267k €38k
better than 95% of 5346 sector peers
Equity €570k €67k
better than 95% of 5349 sector peers
Gross operating margin €371k €66k
better than 95% of 5343 sector peers
Staff costs €48k €20k
higher than 78% of 921 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P73
2020: P58 · n=6522021: P69 · n=18482022: P76 · n=36852023: P73 · n=53472020 2023
Improving position over 2020-2023 · n=652-5347
Net result P95
2020: P18 · n=6532021: P5 · n=18482022: P61 · n=36832023: P95 · n=53462020 2023
Improving position over 2020-2023 · n=653-5346
Equity P95
2020: P92 · n=6522021: P95 · n=18482022: P95 · n=36852023: P95 · n=53492020 2023
Stable position over 2020-2023 · n=652-5349
Gross operating margin P95
2020: P63 · n=6532021: P57 · n=18492022: P84 · n=36812023: P95 · n=53432020 2023
Improving position over 2020-2023 · n=653-5343
Describes the position versus peers, not a forecast.
EBITDA
€209k
-7.2% 18-25
Net profit
€175k
+2.5% 18-25
Cash flow
€184k
-5.6% 18-25
Total assets
€1.27M
+14.4% 18-25
Equity
€734k
+5.0% 18-25
Working capital
€655k
+3.3% 18-25
Employees (FTE)
1
0.0% 18-25
Staff costs
€52k
+6.9% 18-25
Show 12 other metrics
Income taxes
€42k
-62.0% 18-25
Dividends
€140k
- 18-25
Debt
€537k
+30.4% 18-25
Debt ≤ 1y
€477k
+16.2% 18-25
Debt > 1y
€47k
-67.2% 18-25
Current ratio
2.37
-6.7% 18-25
Quick ratio
2.37
-6.7% 18-25
Solvency
57.8%
-8.2% 18-25
Debt / equity
0.73
+24.2% 18-25
ROE
23.9%
-2.4% 18-25
ROA
13.8%
-10.4% 18-25
Interest coverage
113.50
-69.4% 18-25
Figures by fiscal year
Fiscal year2025
Depositmicro
Revenue-
EBITDA€209k
Net profit€175k
Cash flow€184k
Staff costs€52k
Income taxes€42k
Dividends€140k
Total assets€1.27M
Equity€734k
Debt€537k
of which ≤ 1y€477k
of which > 1y€47k
Working capital€655k
Employees (FTE)1.0
Ratios (computed)
2025
Current ratio2.37
Quick ratio2.37
Working capital ratio51.6%
Solvency57.8%
Debt / equity0.73
Long-term debt ratio0.06
Interest coverage113.50
Gross margin-
Net margin-
ROA13.8%
ROE23.9%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2025
Full annual accounts (25 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2025
Balance sheet, Assets
TOTAL ASSETS 20/58€1.27M
Fixed assets 21/28€138k
Tangible fixed assets 22/27€70k
Financial fixed assets 28€68k
Current assets 29/58€1.13M
Amounts receivable within one year 40/41€392k
Investments 50/53€678k
Cash & bank 54/58€60k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€1.27M
Equity 10/15€734k
Contributions / capital 10/11€12k
Reserves 13€722k
Accumulated profits (losses) 14€0
Amounts payable 17/49€537k
Amounts payable after one year 17€47k
Amounts payable within one year 42/48€477k
Trade debts payable within one year 44€5k
Income statement
Gross operating margin 9900€266k
Operating result 9901€201k
Financial income 75€19k
Financial charges 65€2k
Result before taxes 9903€217k
Income taxes 67/77€42k
Net result for the period 9904€175k
Result to be appropriated 9905€91k
This table shows the latest fiscal year. 4 prior years, with figures and ratios, belong to a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2025 · computed
100 / 100 Excellent
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

from the Crossroads Bank
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Arsenaalstraat 33/A8620 Nieuwpoort

Establishment units

1 location
DERMATOLOOG DR. DEVOS
Arsenaalstraat 33, 8620 NieuwpoortActiviteiten van medisch specialisten
since 20122.208.343.966
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area64 m²
Buildings1
Building footprint64 m²
Volume (LiDAR)438 m³
Tallest building8.9 m · ±2 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
38016B0851/00A002 Flanders 64 m² 1 · 64 m² 8.9 m · 2 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

2 acts
Address history · 2
03-05-2023
Registered-office move
24-01-2022
Registered-office move
All acts · 2 updated 3 years ago
2023
03-05-2023 Registered office moved within Nieuwpoort Registered-office change·Xavier De Maesschalck
  • 8620 Nieuwpoort, Arsenaalstraat 33/A → 8620 Nieuwpoort, Arsenaalstraat 33/A
Notary: Xavier De Maesschalck · Oostende
2022
24-01-2022 Registered office moved from Oostende to Nieuwpoort Registered-office change·DE CRIFFIER
  • Karel Janssenslaan 41, 8400 Oostende → Arsenaalstraat 33 A 8620 Nieuwpoort
Notary: DE CRIFFIER · Gent

Analysis

Financial profile

5 of 5 axes measured
Health100Profitability100Solvency98Growth78Stability100
95 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 100
Profitability 100
Solvency 98
Growth 78
Stability 100

Credit advice

verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Medische praktijken85120Activiteiten van medisch specialisten86220Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen68203Overige vormen van onderwijs85599
Primary activity highlighted.
Names & trade names
Legal nameNL DERMATOLOOG DR. DEVOS
Registered office
Arsenaalstraat 33/A
8620 Nieuwpoort, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.